The end of the financial year has been a very busy time for Kalparrin. The board has been looking to the future and how it can build on the good work of Kalparrin ensuring that it remains focussed on making a positive difference to the lives of families and carers of children with special needs through the provision of practical and emotional support.
We have taken some time to review the mission, values and purpose of Kalparrin to ensure we are meeting the needs of our families and that we are positioned to meet the challenges that face any small not-for-profit organisation in the current economic climate.
Key areas of focus for the board include continuing to support the needs of our families in the best way possible, preparing ourselves for the implementation of the NDIS, building Kalparrin’s brand in the community with the aim of securing and sourcing more revenue and positioning ourselves in the sector and at the new hospital so we are able to best serve our families.
To assist us in reaching these objectives we have established and filled the new General Manager position at Kalparrin and we are very excited to welcome Christine Stott to the role.
Christine has extensive management and leadership experience in the Corporate sector and growing a small not-for-profit organisation, which included overseeing operational delivery, developing and implementing processes and policy, sourcing funding and partners, advocacy and leadership in the community.
More recently Christine has been a senior manager at Ngala and has been responsible for developing and running major programs for Ngala that support families. Christine brings a wealth of knowledge and experience to the GM role as well as personal experience of life with a child with special needs.
We have also welcomed to the board Jenny Downs, Senior Research Officer from the Telethon Kids Institute – Jenny has worked at the Telethon Kids Institute since 2005 with a previous clinical background in paediatric physiotherapy.
Her current research program is in intellectual disability with a focus on Rett Syndrome and she has used cohort, observational and qualitative study designs. Other research interests include the CDKL5 disorder, Duchenne Muscular Dystrophy and Early Onset Scoliosis, and early development during infancy. Jenny has a particular interest in comprehensive outcomes research for children and their families, the translation of research findings into clinical practice, and working with consumers to develop meaningful research programs.
We are delighted to have both Jenny and Chris on board at Kalparrin and know that their contribution will help build Kalparrin’s future.
In coming weeks the board will meet with Ernst and Young to discuss the facilitation of a new strategic plan for Kalparrin – we look forward to sharing the outcome of this process with our members in due course.
In closing, on behalf of the board I would like to thank and acknowledge the great work of the Kalparrin staff and volunteers who have taken on a lot of additional work and responsibilities while we fill the GM role. Our staff are extremely dedicated to the work of Kalparrin in supporting our families and their needs and we acknowledge and thank them for their contribution.
We would also like to thank all members and friends of Kalparrin for your ongoing support; we look forward to working with you to help build Kalparrin’s future.